A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai

NCT05387304 · tracked via the Priya Life Science China tracker

Sponsor

Ruijin Hospital

Phase

Observational

Started

2022-03-29

Last updated

2022-05-24

Condition(s) studied

COVID-19

Study summary

This study is to clarify the distribution characteristics, host and clinical characteristics, disease outcome and risk factors, changes of multiple organs such as cardiopulmonary function and changes in social and psychological indicators during long-term follow-up of omicron variant asymptomatic infections and diagnosed patients

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * SARS-Cov-2-RNA positive * informed consent signed Exclusion Criteria: * informed consent rejected

Primary outcome measure(s)

long-term outcomes，changes of clinical characteristic and social psychology — 10 years
the 3rd，6th，9th month，average one year discharge from hospital

Trial sites (1)

Facility	City	Region	Status
Ruijin Hospital	Shanghai	China	Recruiting

More Ruijin Hospital trials in China

PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma Recruiting

A Multimodal Prospective Cohort Study of Parkinsonism Recruiting

PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques Recruiting

The Efficacy of Allo-HSCT in ND HR-CBF-AML Recruiting

Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7% Recruiting

Other trials for the same condition

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19 Recruiting

Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer Starting soon

Transcranial Ultrasound Stimulation for Cognitive Function Modulation in Patients With Post COVID-19 Brain Fog Recruiting

Smart Analysis and Decision-Making for Emerging Infectious Diseases Enrolling by invitation

COVID-19 Immunity and Changes Over Time Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05387304 on ClinicalTrials.gov ↗ ← All trials in China